Flagship Pioneering

Summary

Flagship Pioneering appeared to be the VC, which was created in 2000. The main department of described VC is located in the Cambridge. The venture was found in North America in United States.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Manufacturing, Therapeutics. Among the various public portfolio startups of the fund, we may underline Moderna Therapeutics, Receptos, Indigo Agriculture The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The current fund was established by Edwin Kania, Noubar Afeyan. We also calculated 24 valuable employees in our database.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The real fund results show that this VC is 8 percentage points more often commits exit comparing to other companies. The fund is constantly included in 7-12 deals per year. The top amount of exits for fund were in 2019. The top activity for fund was in 2009. The average startup value when the investment from Flagship Pioneering is more than 1 billion dollars. Comparing to the other companies, this Flagship Pioneering performs on 4 percentage points less the average number of lead investments.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Flagship Pioneering, startups are often financed by Kleiner Perkins, ARCH Venture Partners, OneLiberty Ventures. The meaningful sponsors for the fund in investment in the same round are Venrock, Third Rock Ventures, Khosla Ventures. In the next rounds fund is usually obtained by NanoDimension, Khosla Ventures, General Catalyst.